These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 1726165)
1. Antibody prevalence of parenterally transmitted viruses (HIV-1, HTLV-I, HBV, HCV) in Austrian intravenous drug users. Pont J; Neuwald C; Salzner G Infection; 1991; 19(6):427-30. PubMed ID: 1726165 [TBL] [Abstract][Full Text] [Related]
2. [Antibody prevalence for hepatitis C and other parenterally transmissible viral diseases in i. v. drug dependent patients]. Neuwald C; Pont J; Tomasits J; Bauer K Acta Med Austriaca; 1992; 19(2):47-8. PubMed ID: 1324551 [TBL] [Abstract][Full Text] [Related]
3. Seroepidemiology of viral infections among intravenous drug users in northern California. Zeldis JB; Jain S; Kuramoto IK; Richards C; Sazama K; Samuels S; Holland PV; Flynn N West J Med; 1992 Jan; 156(1):30-5. PubMed ID: 1310362 [TBL] [Abstract][Full Text] [Related]
4. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418 [TBL] [Abstract][Full Text] [Related]
5. [Anti-HCV antibodies in i.v. drug-dependent prisoners under serological surveillance for HIV]. Tanzi ML; Zoni R; Bracchi U; Bellelli E Ann Ig; 1992; 4(5):283-7. PubMed ID: 1284900 [No Abstract] [Full Text] [Related]
6. Heterosexual and homosexual transmission of hepatitis C virus: relation with hepatitis B virus and human immunodeficiency virus type 1. Corona R; Prignano G; Mele A; Gentili G; Caprilli F; Franco E; Ferrigno L; Giglio A; Titti F; Bruno C Epidemiol Infect; 1991 Dec; 107(3):667-72. PubMed ID: 1661241 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of hepatitis C antibodies in patients with clotting disorders in Victoria. Relationship with other blood borne viruses and liver disease. Leslie DE; Rann S; Nicholson S; Fairley CK; Gust ID Med J Aust; 1992 Jun; 156(11):789-92. PubMed ID: 1321326 [TBL] [Abstract][Full Text] [Related]
8. Antibody to hepatitis C virus in selected groups of a Canadian urban population. Anand CM; Fonseca K; Walle RP; Powell S; Williams M Int J Epidemiol; 1992 Feb; 21(1):142-5. PubMed ID: 1312068 [TBL] [Abstract][Full Text] [Related]
9. Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV. Tor J; Llibre JM; Carbonell M; Muga R; Ribera A; Soriano V; Clotet B; Sabriá M; Foz M BMJ; 1990 Nov; 301(6761):1130-3. PubMed ID: 2174705 [TBL] [Abstract][Full Text] [Related]
10. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey. Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255 [TBL] [Abstract][Full Text] [Related]
11. HIV, HTLV-1, and HBV infections in a cohort of Italian intravenous drug abusers: analysis of risk factors. Titti F; Rezza G; Verani P; Buttò S; Sernicola L; Rapicetta M; Sarrecchia B; Oliva C; Rossi GB J Acquir Immune Defic Syndr (1988); 1988; 1(4):405-11. PubMed ID: 3216321 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro. Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022 [TBL] [Abstract][Full Text] [Related]
13. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users. Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of antibodies to human immunodeficiency virus (HIV), hepatitis B and hepatitis C and risk factors in prisoners in Lebanon. Mahfoud Z; Kassak K; Kreidieh K; Shamra S; Ramia S J Infect Dev Ctries; 2010 Mar; 4(3):144-9. PubMed ID: 20351454 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B and hepatitis C in emergency department patients. Kelen GD; Green GB; Purcell RH; Chan DW; Qaqish BF; Sivertson KT; Quinn TC N Engl J Med; 1992 May; 326(21):1399-404. PubMed ID: 1373867 [TBL] [Abstract][Full Text] [Related]
16. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices. Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471 [TBL] [Abstract][Full Text] [Related]
17. Not all injection drug users are created equal: heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia. Kuniholm MH; Aladashvili M; Del Rio C; Stvilia K; Gabelia N; Chitale RA; Tsertsvadze T; Nelson KE Subst Use Misuse; 2008; 43(10):1424-37. PubMed ID: 18696377 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C contributes to liver disease in children and adolescents with hemophilia. Wagner N; Rotthauwe HW Klin Padiatr; 1994; 206(1):40-4. PubMed ID: 7512169 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus antibodies in homosexual men and intravenous drug users in Denmark. Westh H; Worm AM; Jensen BL; Kroon S; Kvinesdal B; Nielsen CM; Wantzin P Infection; 1993; 21(2):115-7. PubMed ID: 7684028 [TBL] [Abstract][Full Text] [Related]
20. [Serological markers of selected viral infections transmitted by parenteral route in drug addicts]. Halota W; Opoka J; Trzciński J; Dorau M; Topczewska E; Giziński W; Bulik F Przegl Epidemiol; 1991; 45(4):347-9. PubMed ID: 1668703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]